Advanced Drug Delivery
Course, Master's level, 3FG011
Expand the information below to show details on how to apply and entry requirements.
Autumn 2025 Autumn 2025, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 1 September 2025–1 October 2025
- Language of instruction
- English
- Entry requirements
-
150 credits, including 120 credits from courses in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) pharmaceutics and pharmacokinetics 15 credits or (2) Molecular Biopharmaceutics 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits in science and engineering (maximum 240 credits)
- Fees
- If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 April 2025
- Application code
- UU-39006
Admitted or on the waiting list?
- Registration period
- 22 August 2025–31 August 2025
- Information on registration from the department
Autumn 2025 Autumn 2025, Uppsala, 100%, On-campus, English For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 1 September 2025–1 October 2025
- Language of instruction
- English
- Entry requirements
-
150 credits, including 120 credits from courses in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) pharmaceutics and pharmacokinetics 15 credits or (2) Molecular Biopharmaceutics 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
- Registration period
- 22 August 2025–31 August 2025
- Information on registration from the department
Expand the information below to show details on how to apply and entry requirements.
Autumn 2026 Autumn 2026, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 31 August 2026–30 September 2026
- Language of instruction
- English
- Entry requirements
-
150 credits, including 120 credits from courses in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) pharmaceutics and pharmacokinetics 15 credits or (2) Molecular Biopharmaceutics 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits in science and engineering (maximum 240 credits)
- Fees
- If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 20,625
- Total tuition fee: SEK 20,625
- Application deadline
- 15 April 2026
- Application code
- UU-39006
Admitted or on the waiting list?
Autumn 2026 Autumn 2026, Uppsala, 100%, On-campus, English For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 31 August 2026–30 September 2026
- Language of instruction
- English
- Entry requirements
-
150 credits, including 120 credits from courses in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) pharmaceutics and pharmacokinetics 15 credits or (2) Molecular Biopharmaceutics 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
About the course
The course gives a deep understanding of the molecular properties of drugs and how they affect the choice of drug delivery system and administration route. Furthermore, it describes how pharmacokinetic and pharmacodynamic models are used to predict the bioavailability and effect of drugs for different administration routes.
We relate barrier properties (physiological, biochemical, chemical), transport proteins and enzymes to their importance for drug delivery via different administration routes. This includes cell culture models to study mechanisms of drug transport across biological barriers.
We study intracellular drug delivery and subcellular drug distribution and how to choose appropriate drug delivery systems so that drugs can cross these barriers. The course will furthermore cover formulation principles for different administration routes; pulmonary, parenteral, oral, dermal and vaginal. This includes colloidal and semi-solid systems (e.g. liposomes, gels), solid mesoporous carriers, nanocarriers and prodrug strategies as well as advanced characterisation methods for drug delivery systems in silico and in vitro.
Finally, we will discuss regulatory aspects when choosing a drug delivery system and dosage form.